The companies, including Ranbaxy, Dr Reddy's Lab, Glenmark, Cipla and Cadilla, were found to be overcharging patients on Doxofylline.
New Delhi: Nine pharmaceutical companies have been fined Rs 2500 crore by the National Pharmaceutical Pricing Authority (NPPA) for overcharging customers.
The NPPA imposed penalty after the drug makers, which also include Ranbaxy, Dr. Reddy's Lab, Glenmark, Cipla and Cadilla, were overcharging patients on Doxofylline.
The asthma drug was being sold between Rs 80-110 per strip.
Comments
0 comment